CLASS II Device recall · Reported 16 Jan 2019 · FDA Enforcement Report

Proteus 235 Product Usage: The Proton Therapy System - Proteus recalled

Ion Beam Applications is recalling Proteus 235 Product Usage: The Proton Therapy System - Proteus 235, distributed nationwide in the US. The recall was initiated on 12 Dec 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSAT.123, SBF.101, SBF.103, SBF.104, SBF.105, SBF.107, SBF.109
Quantity recalled7

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0698-2019
FDA event ID
81807
Recalling firm
Ion Beam Applications, Louvain-la-neuve
Classification
Class II
Status
Terminated
Recall initiated
12 Dec 2018
FDA classified
8 Jan 2019
Reported
16 Jan 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Dec 2018Recall initiated by company
8 Jan 2019Classified by FDA+27 days
16 Jan 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a risk of detachment of the Compact Gantry Rolling Floor.

Product as listed by the FDA

Proteus 235 Product Usage: The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

Where it was distributed

Worldwide Distribution - US Nationwide in the states of LA and MI. Foreign distribution to France, Japan, and UK.

Nationwide LouisianaMichigan

Questions about this recall

Why was it recalled?

There is a risk of detachment of the Compact Gantry Rolling Floor.

Which lots are affected?

SAT.123, SBF.101, SBF.103, SBF.104, SBF.105, SBF.107, SBF.109

Where was it sold?

Worldwide Distribution - US Nationwide in the states of LA and MI. Foreign distribution to France, Japan, and UK.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ion Beam Applications

All 36

Other Other Medical Devices recalls

All 13,929